• Title/Summary/Keyword: National Cancer Database

Search Result 212, Processing Time 0.026 seconds

Participation Rate and Related Socio-demographic Factors in the National Cancer Screening Program (국가 암조기검진사업 참여에 영향을 미치는 인구사회학적 요인)

  • Sung, Na-Young;Park, Eun-Cheol;Shin, Hai-Rim;Choi, Kui-Son
    • Journal of Preventive Medicine and Public Health
    • /
    • v.38 no.1
    • /
    • pp.93-100
    • /
    • 2005
  • Background : Cancer is the leading cause of death and one of the largest burdens of disease in Korea. In 1996, the Ten year Plan for Cancer Control was formulated and the government then adopted the plan as a national policy. As part of this plan, the National Cancer Screening Program (NCSP) for Medicaid recipients was formulated, and the government adapted this in 1999. For low-income beneficiaries of the National Health Insurance Corporation (NHIC), the screening program has been in place since 2002. In 2002, the target cancers of NCSP were stomach, breast and cervical cancer. This study was conducted to examine the relationships between the participation rate, the abnormal screening rate and the socio-demographic factors associated with participation in the screening program. Methods : To analyze the participation rate and abnormal rate for the NCSP, we used the 2002 NCSP records. The information on the socio-demographic factors was available from the database of the beneficiaries in the NHIC and Medicaid. Results : The participation rate of the Medicaid beneficiaries for the stomach, breast and cervical cancer screening were 9.2%, 15.5% and 15.0%, respectively, and 11.3% and 12.5%, except cervical cancer which wasn't be included in the NCSP, for the beneficiaries of the NHIC. The abnormal rate of stomach, breast and cervical cancer screening were 25.7%, 11.2% and 21.0%, respectively, for the beneficiaries of Medicaid and 42.6% and 19.4% for the beneficiaries of the NHIC. On the multiple logistic regression analysis, gender, age and place of residence were significantly associated with participation rates of the NCSP. For stomach cancer, women participated in the NCSP more than men. The participation rate was higher among people in their fifties and sixties than for those people in their forties and those people over seventy years in age. For the breast and cervical cancer, people in their fifties were more likely to participate in the NCSP than people in their forties and people over sixty. For the place of residence, people in the rural areas participated more than those people in any other places. Conclusions : The above results show that the participation rate and abnormal rate were significantly associated with the socio-demographic factors. To improve the participation rate for the NCSP, more attention should be given to the underserved groups.

Bibliometric Analysis of the Effect of Acupuncture on Cancer Pain in the Last 20 Years (최근 20년간 침의 암성통증에 대한 효과 연구의 계량서지학적 분석)

  • Park, Han-song;Lee, Do-eun;Ha, Ji-su;Seo, Ho-seok;Kim, Jin-won
    • The Journal of Internal Korean Medicine
    • /
    • v.42 no.3
    • /
    • pp.279-292
    • /
    • 2021
  • Objectives: Analyze papers on the effect of acupuncture on cancer pain from a macroscopic point of view, suggesting global trends and future research directions to promote acupuncture treatment for cancer pain. Methods: By filtering the papers searched for (acupuncture) AND (cancer pain) in the Web of Science database, 351 papers were selected and analyzed by year, field, journal, institution, author, and keyword. Results: Most papers were published in 2020, and research was active in the field of complementary and alternative medicine. Research on the effects of acupuncture in cancer pain has been active in cancer centers and university hospitals, research has been active in various countries. The most frequently mentioned keywords in the titles and abstracts were acupuncture, pain, and quality of life. The latest top 5 keywords were inhibitor-induced arthralgia, acupuncture therapy, risk factors, opioids, and recovery. Conclusions: Acupuncture treatment has the potential to reduce pain and improve quality of life in cancer patients, and it should be actively studied in the future.

Neoadjuvant Chemotherapy and Prognosis of Pregnancy-Associated Breast Cancer: A Time-Trends Study of the Korean Breast Cancer Registry Database

  • Bae, Soo Youn;Kim, Ku Sang;Kim, Jeong-Soo;Lee, Sae Byul;Park, Byeong-Woo;Lee, Seok Won;Lee, Hyouk Jin;Kim, Hong Kyu;You, Ji-Young;Jung, Seung Pil;Korean Breast Cancer Society
    • Journal of Breast Cancer
    • /
    • v.21 no.4
    • /
    • pp.425-432
    • /
    • 2018
  • Purpose: Pregnancy-associated breast cancer (PABC) is rare, and its cause and prognosis are not well known. Additionally, treatment is limited with respect to the risk to the fetus. The purpose of this study was to investigate the characteristics and treatment trends of PABC and the survival rate according to the treatment. Methods: In the Korean Breast Cancer Society Registry database, women younger than 50 years and who were diagnosed with breast cancer from 1996 to 2015 were included. PABC was defined as breast cancer diagnosed during pregnancy or within 1 year after delivery. Results: We examined 411 patients with PABC and 83,381 patients with non-PABC. Over time, the proportions of patients undergoing breast-conserving surgery and sentinel lymph node biopsy increased, and neoadjuvant chemotherapy and radiation therapy administration rates also increased. In the past, the overall survival of patients with PABC was poorer than that of patients with non-PABC, but there was no difference in overall survival rates in more recent years. There was no difference in overall survival rates between patients who received neoadjuvant chemotherapy (hazard ratio [HR], 1.28; 95% confidence interval [CI], 0.66-2.49; p=0.459), but PABC conferred poorer prognosis than non-PABC in patients receiving adjuvant chemotherapy (HR, 1.63; 95% CI, 1.27-2.08; p<0.001). Conclusion: There was no difference in the prognosis between patients with PABC and those with non-PABC receiving neoadjuvant chemotherapy. The increase in neoadjuvant chemotherapy according to current treatment guidelines is expected to improve the survival rate of patients with PABC.

Induction Chemotherapy Followed by Concurrent Chemoradiotherapy Versus Concurrent Chemoradiotherapy with or without Adjuvant Chemotherapy for Locoregionally Advanced Nasopharyngeal Carcinoma: Meta-analysis of 1,096 Patients from 11 Randomized Controlled Trials

  • Liang, Zhong-Guo;Zhu, Xiao-Dong;Tan, Ai-Hua;Jiang, Yan-Ming;Qu, Song;Su, Fang;Xu, Guo-Zeng
    • Asian Pacific Journal of Cancer Prevention
    • /
    • v.14 no.1
    • /
    • pp.515-521
    • /
    • 2013
  • Purpose: To evaluate the efficacy and toxicity of induction chemotherapy followed by concurrent chemoradiotherapy (the treatment group) versus concurrent chemoradiotherapy with or without adjuvant chemotherapy (the control group) for locoregionally advanced nasopharyngeal carcinoma. Methods: The search strategy included Pubmed, Embase, the Cochrane Library, China National Knowledge Internet Web, Chinese Biomedical Database and Wanfang Database. We also searched reference lists of articles and the volumes of abstracts of scientific meetings. All randomized controlled trials were included for a meta-analysis performed with RevMan 5.1.0. The Grading of Recommendations Assessment, Development, and Evaluation system (GRADE) was used to rate the level of evidence. Results: Eleven studies were included. Risk ratios of 0.99 (95%CI 0.72-1.36), 0.37 (95%CI 0.20-0.69), 1.08 (95%CI 0.84-1.38), 0.98 (95%CI 0.75-1.27) were observed for 3 years overall survival, 3 years progression-free survival, 2 years loco-regional failure-free survival and 2 years distant metastasis failure-free survival. There were no treatment-related deaths in either group in the 11 studies. Risk ratios of 1.90 (95%CI 1.24-2.92), 2.67 (95%CI 0.64-11.1), 1.04 (95%CI 0.79-1.37), 0.98 (95%CI 0.27-3.52) were found for grade 3-4 leukopenia, grade 3-4 thrombocytopenia, grade 3-4 mucous membrane, and grade 3-4 hepatic hematologic and gastrointestinal toxicity, the most significant toxicities for patients. Conclusion: Compared with the control group, induction chemotherapy followed by concurrent chemoradiotherapy was well tolerated but could not significantly improve prognosis in terms of overall survival, loco-regional failure-free survival or distant metastasis failure-free survival.

A Validation of Estimating the National Cancer Incidence in Korea using the Databases of 7 Population-based Regional Cancer Registries except Seoul (서울을 제외한 7개 지역암등록본부 자료를 활용한 국가 암통계 추정의 타당성)

  • Bae, Jong-Myeon
    • Journal of Preventive Medicine and Public Health
    • /
    • v.42 no.2
    • /
    • pp.130-134
    • /
    • 2009
  • Objectives : A method of estimation using 8 populationbased cancer registries databases in Korea(KRCR DB) has been introduced as another strategy for validly estimating the national cancer incidence(NCI) in Korea. The purpose of this study was to evaluate the validity of this method with using the 7 KRCR DBs, excluding Seoul covering 21% of the total population of Korea. Methods : We designed the study method(NCSE_7) as same as the estimating method with using 8 KRCR DBs (NCSE_8) in order to ensure maximal comparability. We defined the expected number of cancer cases in each registry as the number of observed cases and then we added the weighted observed cases according to gender, age and the proportion of the population covered by each registry for the population of the seven regions and the population of all areas, with excluding these seven regions. From the expected number of total cancer incidents, the estimated NCI was calculated by dividing the expected number of cancer cases by the number of the total population. The standard error(SE) of the estimated incidence was also taken from the expected number of total cancer incidents. Results : Compared with the results of the NCSE_8, the overall age-standardized rates(ASR) in men and women became over-estimated and under-estimated, respectively. Primary sites that showed statistically significant differences were the colo-rectum, prostate, breast and thyroid. The index of death certificate only(DCO)and microscopically verified(MV)% indicating levels of data quality were decreased, especially for the brain in DCO% and kidney in the MV%. Conclusions : The database of Seoul regional cancer registry has a key role for the method to estimate the valid nationwide cancer statistics in Korea with using the population-based cancer registries databases.

Tissue factor expression is associated with recurrence in patients with non-metastatic colorectal cancer

  • Jung, Hee Jae;Kim, Hye Jin;Kaneko, Kensuke;Kazama, Yoshihiro;Kawai, Kazushige;Ishihara, Soichiro;Choi, Gyu-Seog
    • Korean Journal of Clinical Oncology
    • /
    • v.14 no.2
    • /
    • pp.128-134
    • /
    • 2018
  • Purpose: Previous studies have addressed the role of the hypercoagulable state in the pathogenesis of cancer progression and metastasis. In this study, we investigated the association between coagulation factors, including tissue factor (TF) expression, platelet count, and fibrinogen level, and disease recurrence in patients with non-metastatic colorectal cancer. Methods: Patients who underwent curative resection for stage II or III colorectal cancer between 2000 and 2007 were included in this study. Data from a prospectively maintained database were retrospectively reviewed. TF expression was determined by immunohistochemistry using an anti-TF monoclonal antibody. The Kaplan-Meier method was used to estimate 5-year disease-free survival. Results: TF was highly expressed in 257 of 297 patients (86.5%). TF expression was not significantly associated with the platelet counts (P=0.180) or fibrinogen level (P=0.281). The 5-year disease-free survival rate was lower in patients with high TF expression than in patients with low TF expression (72.3% vs. 83.9%, P=0.074). In Cox hazard analysis, high TF expression was an independent risk factor for tumor recurrence (hazard ratio [HR] 2.446; 95% confidence interval [CI], 1.054-5.674; P=0.037). Undifferentiated histologic type (HR, 2.911; 95% CI, 1.308-6.481; P=0.009), venous invasion (HR, 2.784; 95% CI, 1.431-5.417; P=0.003), and lymph node metastasis (HR, 2.497; 95% CI, 1.499-4.158; P<0.001), were also significantly associated with disease recurrence. Conclusion: TF expression is associated with a recurrence in patients with non-metastatic colorectal cancer. However, further studies are required to clarify the underlying mechanisms relating TF expression with oncologic outcomes and its potential role as a therapeutic target.

Global Histidine Phosphoproteomics in Human Prostate Cancer Cells

  • Gao, Yan;Kim, Doeun;Sung, Eunji;Tan, Minjia;Kwon, Tae Gyun;Lee, Jun Nyung;Lee, Sangkyu
    • Mass Spectrometry Letters
    • /
    • v.11 no.3
    • /
    • pp.52-58
    • /
    • 2020
  • Histidine phosphorylation (pHis) is increasingly recognized as an important post translational modification (PTM) in regulating cellular functions in eukaryotes. In order to clarify the role of pHis in mammalian cell signaling system, a global phosphorylation study was performed in human prostate cancer cells, PC-3M, using a TiO2 affinity chromatography. A total number of 307 pHis sites were identified on the 268 proteins among total identified 9,924 phosphorylation sites on 3,316 proteins. In addition, 22 pHis proteins were classified in enzyme category. This report provides the first database for the study of pHis in prostate cancer cells.

Cancer Incidence in Korean Vietnam Veterans During 1992-2003: The Korean Veterans Health Study

  • Yi, Sang-Wook
    • Journal of Preventive Medicine and Public Health
    • /
    • v.46 no.6
    • /
    • pp.309-318
    • /
    • 2013
  • Objectives: The aim of this study was to investigate the association between Vietnam experience including exposure to military herbicides and cancer incidence in Korean Vietnam War veterans. Methods: The cancer cases of 185 265 Vietnam veterans from January 1, 1992 to December 31, 2003 were confirmed from the Korea National Cancer Incidence Database. The age-adjusted incidence and standardized incidence ratios (SIRs) were calculated using the male population during 1992 to 2003 as a standard population. Results: The age-adjusted overall cancer incidence per 100 000 person-years was 455.3 in Vietnam veterans. The overall cancer incidence was slightly yet significantly lower in veterans (SIR, 0.97; 95% confidence interval, 0.95 to 0.99) than in the general population. The overall cancer incidence in enlisted soldiers was not lower (SIR, 1.00), whereas that in officers was significantly lower (SIR, 0.87) than in the general population. The incidences of prostate cancer and T-cell lymphoma in all veterans, and lung cancer and bladder cancer in enlisted soldiers, and colon cancer and kidney cancer in non-commissioned officers, and colon cancer, kidney cancer, and prostate cancer in officers, were higher than in the general population. The SIR for overall cancer among Vietnam veterans rose from 0.92 for 1992-1997 to 0.99 for 1998-2003. Conclusions: The overall cancer incidence in Vietnam veterans was not higher than in the general male population. Vietnam veterans and military rank subcohorts experienced a higher incidence of several cancers, including prostate cancer, T-cell lymphoma, lung cancer, bladder cancer, kidney cancer, and colon cancer than the general population. The SIR for overall cancer increased over time in Vietnam veterans.

Association between Relative Preference for Vegetables and Meat and Cancer Incidence in Korean Adults: A Nationwide Population-based Retrospective Cohort Study (채소 및 육류 섭취의 상대적인 선호도와 암 발생의 연관성: 국민건강보험공단 국민건강정보자료 활용)

  • Yie, Ga-Eun;Kim, An Na;Cho, Hyun Jeong;Kang, Minji;Moon, Sungji;Kim, Inah;Ko, Kwang-Pil;Lee, Jung Eun;Park, Sue K.
    • Korean Journal of Community Nutrition
    • /
    • v.26 no.3
    • /
    • pp.211-227
    • /
    • 2021
  • Objectives: We aimed to examine the association between the relative preference for vegetables and meat and cancer incidence, in a population-based retrospective cohort in Korea. Methods: We included 10,148,131 participants (5,794,124 men; 4,354,007 women) who underwent national health screening between 2004 and 2005 from the National Health Information Database of the National Health Insurance Service (NHIS-NHID). Participants were asked whether they preferred consuming 1) vegetables more often, 2) both vegetables and meat or 3) meat more often. Participants were followed up to Dec. 31, 2017. All cancer and eighteen common cancer cases were identified through the code from the International Classification of Diseases, 10th revision. We estimated sex-specific relative risks and 95% confidence intervals, adjusting for age, body mass index, alcohol consumption, smoking, physical activity, and income level. Results: During an average follow-up of 12.4 years, 714,170 cancer cases were documented. In men, consuming meat more often was associated with lower risk of esophageal, liver, and stomach cancers, but higher risk of lung and kidney cancers. Consuming both vegetables and meat was associated with higher risk of prostate cancer, but with lower risk of esophageal, liver, and stomach cancers in men. In women, consuming meat more often was associated with a higher risk of colorectal cancer and breast, endometrial, and cervical cancers diagnosed before the age of 50. Consuming both vegetables and meat was associated with lower risk of liver cancer in women. Conclusions: Our study suggests a potential link between vegetable and meat intake and cancer incidence in the Korean population. Further investigation on the association between the intake of specific types of vegetables and meat and cancer risk in Korean prospective cohort studies is needed.